Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMRO in Relapsed/Refractory PTCL
NCT01822886Phase 2Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Jan 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in peripheral T-cell lymphoma (PTCL), sponsored by Fondazione Italiana Linfomi. Started Jan 2013; status: completed.
02
Drugs
romidepsin
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT01822886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01822886.